Liquet™ Medical Receives Second FDA 510(k) Clearance for Versus™ Catheter
Liquet Medical Inc., a pioneering medical device company committed to advancing patient care through innovative technologies, today announced it has received a second 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new configuration of the Versus™ Catheter. The latest clearance expands the company’s proprietary platform and opens access to a broader segment of interventional physicians. The Versus Catheter provides real-time pulmonary artery (PA) pressure measurements to empower clinicians to optimize treatment based on each individual patient’s response. This novel technology grows the new treatment category of “Hemodynamics-Led Thrombolysis (HLT),” a physiology-guided approach.
As blood clot procedures evolve towards more rapid treatment strategies, the Versus™ Catheter is uniquely positioned to fit perfectly within this new paradigm.
